Pradaxa Lawsuit News: Trials Scheduled
Patients are currently filing claims against Boehringer Ingelheim International, manufacturer of the well-known blood thinner Pradaxa, alleging that the medication causes internal bleeding and an increased risk of death. According to several recent Pradaxa lawsuit news updates, although many have taken the medication and compare it to warfarin in function and design, others have reportedly suffered from life-threatening and severe complications and are currently seeking compensation for their conditions.
Those who have taken the blood thinner Pradaxa may be entitled to file a claim and hold the manufacturer accountable for their injuries if they experienced adverse side effects while using the medication. Contact the American Injury Attorney Group today for more information about the latest Pradaxa lawsuit news and to determine whether you have a valid case.
Pradaxa Lawsuit News
A federal judge overseeing Pradaxa lawsuits alleging that the medication caused serious complications such as internal bleeding and death has recently announced the first Pradaxa lawsuits for trial. Judge David R. Herndon, who is presiding over the multi-district litigation in the U.S. District Court, Southern District of Illinois, has set the following schedule for the first four bellwether trials:
- August 11, 2014
- November 3, 2014
- January 5, 2015
- February 16, 2015
According to the most recent Pradaxa lawsuit news updates, there are currently 2,057 cases filed in the consolidation of federal cases currently proceeding in the U.S. District Court, Southern District of Illinois as of January 15, 2014.
Judge Herndon also unsealed dozens of documents in the litigation over Pradaxa on January 29, 2014, finding that Boehringer Ingelheim had not sufficiently explained why it had marked them as confidential. Judge Herndon granted the plaintiffs’ motion to remove the confidential label on 85 separate documents and made exceptions for specific German custodial documents that he stated should only be released in redacted form.
Plaintiffs currently filing lawsuits against the manufacturer claim that Boehringer Ingelheim knew, or should have known, about the potential complications that could occur while taking Pradaxa. Additionally, Pradaxa was released without an antidote, unlike other blood thinners, so patients are automatically at a higher risk of internal bleeding and “bleed-out” deaths.
What is Pradaxa?
Approved by the U.S. Food and Drug Administration in 2010 to treat strokes and blood clots in those with atrial fibrillation, Pradaxa has recently raised concerns about whether the medication increases patients’ risks of internal bleeding.
Additionally, the Institute for Safe Medication Practices has released warnings that suggest that patients taking Pradaxa and experiencing internal bleeding may be five times more likely to die from the complications. A recent clinical trial also reported that patients using Pradaxa and other blood thinners may be at a 55 percent increased chance of suffering from internal bleeding.
Although the FDA had stated that Pradaxa is just as safe as warfarin, a traditional blood thinner, the agency is currently planning a new study of data to compare the occurrence rate of blood clots and internal bleeding in atrial fibrillation patients taking warfarin and Pradaxa. The FDA had allegedly received 542 reports of death and 3,781 adverse event reports from patients taking Pradaxa.
Injured and Need Legal Counsel? Contact Us Today
If you or someone you love took Pradaxa and you suffered from injuries or adverse complications that you feel were caused by the medication, contact the American Injury Attorney Group today. We continue to remain up-to-date on the latest Pradaxa lawsuit news and will provide you with a free consultation to help you to determine if you have a valid claim. We will connect you with an affiliated attorney who will work to help you recover the compensation to which you may be entitled.